Results 31 to 40 of about 2,196,135 (231)

sj-tiff-1-jet-10.1177_15266028231214167 – Supplemental material for Effect of High-Dose Drug-Coated Balloon Repetition After Drug-Coated Balloon Failure

open access: yes, 2023
Supplemental material, sj-tiff-1-jet-10.1177_15266028231214167 for Effect of High-Dose Drug-Coated Balloon Repetition After Drug-Coated Balloon Failure by Yusuke Tomoi, Mitsuyoshi Takahara, Yoshimitsu Soga, Taichi Hirano, Kazuki Tsunoda, Tomonori Katsuki
Tomonori Katsuki (7298834)   +6 more
core   +1 more source

Long-Term Outcome of Drug-Coated Balloon vs Drug-Eluting Stent for Small Coronary Vessels: PICCOLETO-II 3-Year Follow-Up.

open access: yesJACC: Cardiovascular Interventions, 2023
BACKGROUND Native vessel coronary artery disease represents 1 of the most attractive fields of application for drug-coated balloons (DCBs). To date, several devices have been compared with drug-eluting stents (DESs) in this setting with different ...
B. Cortese   +4 more
semanticscholar   +1 more source

Coronary artery restenosis treatment with plain balloon, drug-coated balloon, or drug-eluting stent: 10-year outcomes of the ISAR-DESIRE 3 trial.

open access: yesEuropean Heart Journal, 2023
AIMS The best interventional strategy for the treatment of drug-eluting stent (DES) in-stent restenosis (ISR) is still unclear and no data from randomized trials beyond 3-year follow-up are available.
D. Giacoppo   +12 more
semanticscholar   +1 more source

RIPK3 dampens mitochondrial bioenergetics and lipid droplet dynamics in metabolic liver disease

open access: yesHepatology, EarlyView., 2022
RIPK3 dampens mitochondrial bioenergetics and lipid droplet dynamics in metabolic liver disease. Abstract Background and Aims Receptor‐interacting protein kinase 3 (RIPK3) mediates NAFLD progression, but its metabolic function is unclear. Here, we aimed to investigate the role of RIPK3 in modulating mitochondria function, coupled with lipid droplet (LD)
Marta B. Afonso   +16 more
wiley   +1 more source

The Development of an ex vivo Flow System to Assess Acute Arterial Drug Retention of Cardiovascular Intravascular Devices

open access: yesFrontiers in Medical Technology, 2021
Purpose: The goal of this study was to develop an ex vivo system capable of rapidly evaluating arterial drug levels in living, isolated porcine carotid arteries.Methods: A vascular bioreactor system was developed that housed a native porcine carotid ...
Kathryn Cooper   +5 more
doaj   +1 more source

Drug-coated balloon versus conventional balloon angioplasty of hemodialysis arteriovenous fistula or graft: A systematic review and meta-analysis of randomized controlled trials - Fig 5

open access: yes, 2020
Forest plot of (A) 6-month and (B) 12-month primary patency of access circuit in the DCB arm and the CB arm. Abbreviations: DCB, drug-coated balloon; CB, conventional balloon.
Min-Tsun Liao (4669771)   +7 more
core   +1 more source

Modelling drug coatings: A parallel cellular automata model of ethylcellulose-coated microspheres [PDF]

open access: yes, 2011
Pharmaceutical companies today face a growing demand for more complex drug designs. In the past few decades, a number of probabilistic models have been developed, with the aim of improving insight on microscopic features of these complex designs.
Crane, Martin   +5 more
core   +5 more sources

Drug-coated balloon versus conventional balloon angioplasty of hemodialysis arteriovenous fistula or graft: A systematic review and meta-analysis of randomized controlled trials - Fig 3

open access: yes, 2020
Forest plot of (A) 6-month and (B) 12-month primary patency of target lesion in DCB arm and CB arm. Abbreviations: DCB, drug-coated balloon; CB, conventional balloon;
Min-Tsun Liao (4669771)   +7 more
core   +1 more source

Drug-coated balloon versus conventional balloon angioplasty of hemodialysis arteriovenous fistula or graft: A systematic review and meta-analysis of randomized controlled trials - Fig 4

open access: yes, 2020
Forest plot of (A) 6-month and (B) 12-month target lesion primary patency of AVF only subgroup, non-central venous stenosis subgroup, and AVF and non-central venous stenosis subgroup. Abbreviations: DCB, drug-coated balloon; CB, conventional balloon; CVS,
Min-Tsun Liao (4669771)   +7 more
core   +1 more source

Major adverse limb events in patients with femoro-popliteal and below-the-knee peripheral arterial disease treated with either sirolimus-coated balloon or standard uncoated balloon angioplasty: a structured protocol summary of the “SirPAD” randomized controlled trial

open access: yesTrials, 2022
Background Peripheral arterial disease is a progressive atherosclerotic disease with symptoms ranging from an intermittent claudication to acute critical limb ischemia and amputations. Drug-coated balloons and stents were developed to prevent neo-intimal
Stefano Barco   +12 more
doaj   +1 more source

Home - About - Disclaimer - Privacy